ReviewClinical pharmacokinetics2024

Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug-Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective.

Hee Jae Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.